Abstract
Type 2 diabetes (T2D) often exhibits long-standing disparities across populations. Spatial regression models can identify areas of epidemiological conformity and transitions between local neighborhoods to inform timely, localized public health interventions. We identified areal-level distributions of T2D rates across Malaysia and synthesized prediction models to estimate local effects and interactions of different neighborhood covariates affecting local T2D burden. We obtained aggregated counts of national level T2D cases data by administrative-districts between 2016-2020 and computed district-wise crude rates to correlate with district-level neighborhood demographic, socio-economic, safety, fitness, access to built-environments, and urban growth indicators from various national sources and census data. We applied simultaneous spatial autoregressive (SAR) models coupled with two-way interaction analyses to account for spatial autocorrelation and estimate risk factors for district-level T2D rates in Malaysia. The variation in spatial lag estimates of T2D rates by districts was influenced by the proportion of households living below 50% of the median income (β = 0.009, p = 0.002) and national poverty line (β = - 0.012, p = 0.001), income inequalities (β = - 2.005, p = 0.004), CCTV coverage per 1000 population (β = 0.070, p = 0.023), average property crime index per 1000 population (β = 0.014, p = 0.033), access to bowling centers (β = - 0.003, p = 0.019), and parks (β = 0.007, p = 0.001). Areal-level district-wise crude T2D rate estimates were influenced by neighborhood socio-economic vulnerabilities, neighborhood safety, and neighborhood access to fitness facilities, after accounting for residual spatial correlation via SAR models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Ministry of Higher Education (MOHE) Malaysia Fundamental Research Grant Scheme (FRGS/1/2022/SKK04/UKM/01/1)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Universiti Kebangsaan Malaysia and the Medical Research Ethics Committee (MREC) Ministry of Health Malaysia gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail addresses:
NS: nazarudin{at}ppukm.ukm.edu.my
LAW: lwaller{at}emory.edu
FIM: dr.feisul{at}moh.gov.my
KNAM: knam{at}ukm.edu.my
MFMR: faidrizal{at}yahoo.com
Data Availability Statement
The data that support the findings of this study are available from the authors but restrictions apply to the availability of these data, which were used under license from the relevant agencies for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and with permission from the relevant agencies or ministries.
